Effect of early interferon beta-1a therapy on conversion to multiple sclerosis in Iranian patients with a first demyelinating event.


BACKGROUND A new treatment approach to multiple sclerosis (MS) is the initiation of interferon therapy in the early phase of the disease when a patient presents with clinically isolated syndrome. AIMS OF THE STUDY The goal of this study was to assess the effect of early treatment on the risk of conversion to clinically definite MS in Iranian patients… (More)


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.